Company news from ShareCast
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
Super Bowl, Winter Olympics help Comcast beat Q1 expectations
Thu 23 April 2026 14:06
(Sharecast News) - Comcast beat Wall Street expectations for first-quarter revenue and earnings on Thursday, as a lighter-than-expected decline in broadband customers and a surge in advertising tied to NBC's Super Bowl and Winter Olympics coverage helped
American Express beats estimates on premium member growth, but shares fall
Thu 23 April 2026 13:12
(Sharecast News) - First-quarter results from American Express beat market expectations on Thursday, as revenues rose at a double-digit percentage on the back of strong business from its premium customer base, though shares retreated after hitting a two-m
American Airlines guidance beats forecasts despite $4bn higher fuel costs
Thu 23 April 2026 12:47
(Sharecast News) - American Airlines' share price rose on Thursday despite the company lowering its profit forecasts on the back of an additional $4bn in fuel costs, as first-quarter results revealed that revenues rose to a record high.
Blackstone Q1 earnings come in ahead of forecasts
Thu 23 April 2026 12:35
(Sharecast News) - Blackstone reported first-quarter earnings ahead of expectations, as stronger inflows and asset sales helped offset investor caution over geopolitical turmoil and concerns around parts of the private credit market.
Sanofi shares jump on solid Q1 ahead of new CEO arrival
Thu 23 April 2026 12:11
(Sharecast News) - Shares in Sanofi rose as the French pharma giant beat first-quarter sales estimates on Thursday on continuing demand for its Dupixent asthma and eczema drug just before the arrival of new chief executive Belén Garijo.
Roche confident despite strong Swiss franc, threat of generics
Thu 23 April 2026 12:04
(Sharecast News) - Roche reported a 5% fall in first-quarter sales to CHF 14.7bn (£13.88bn) on Thursday, as the strength of the Swiss franc and generic competition for older drugs weighed on reported results, though sales rose 6% at constant exchange rat